Literature DB >> 21158892

PCOS Forum: research in polycystic ovary syndrome today and tomorrow.

Renato Pasquali1, Elisabet Stener-Victorin, Bulent O Yildiz, Antoni J Duleba, Kathleen Hoeger, Helen Mason, Roy Homburg, Theresa Hickey, Steve Franks, Juha S Tapanainen, Adam Balen, David H Abbott, Evanthia Diamanti-Kandarakis, Richard S Legro.   

Abstract

OBJECTIVE: To summarize promising areas of investigation into polycystic ovary syndrome (PCOS) and to stimulate further research in this area.
DESIGN: Summary of a conference held by international researchers in the field of polycystic ovary syndrome.
RESULTS: Potential areas of further research activity include the analysis of predisposing conditions that increase the risk of PCOS, particularly genetic background and environmental factors, such as endocrine disruptors and lifestyle. The concept that androgen excess may contribute to insulin resistance needs to be re-examined from a developmental perspective, since animal studies have supported the hypothesis that early exposure to modest androgen excess is associated with insulin resistance. Defining alterations of steroidogenesis in PCOS should quantify ovarian, adrenal and extraglandular contribution, as well as clearly define blood reference levels by some universal standard. Intraovarian regulation of follicle development and mechanisms of follicle arrest should be further elucidated. Finally, PCOS status is expected to have long-term consequences in women, specifically the development of type 2 diabetes, cardiovascular diseases and hormone dependent cancers. Identifying susceptible individuals through genomic and proteomic approaches would help to individualize therapy and prevention.
CONCLUSIONS: There are several intriguing areas for future research in PCOS. A potential limitation of our review is that we focused selectively on areas we viewed as the most controversial.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21158892      PMCID: PMC3742326          DOI: 10.1111/j.1365-2265.2010.03956.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  81 in total

1.  The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity.

Authors:  Bill L Lasley; Nanette Santoro; John F Randolf; Ellen B Gold; Sybil Crawford; Gerson Weiss; Daniel S McConnell; Mary Fran Sowers
Journal:  J Clin Endocrinol Metab       Date:  2002-08       Impact factor: 5.958

2.  Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome.

Authors:  R S Legro; A R Kunselman; A Dunaif
Journal:  Am J Med       Date:  2001-12-01       Impact factor: 4.965

3.  Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease.

Authors:  T Sabuncu; H Vural; M Harma; M Harma
Journal:  Clin Biochem       Date:  2001-07       Impact factor: 3.281

4.  Ovarian and adrenal steroid production: regulatory role of LH/HCG.

Authors:  T Piltonen; R Koivunen; L Morin-Papunen; A Ruokonen; I T Huhtaniemi; J S Tapanainen
Journal:  Hum Reprod       Date:  2002-03       Impact factor: 6.918

Review 5.  Sympathetic nerve activity in metabolic control--some basic concepts.

Authors:  J Fagius
Journal:  Acta Physiol Scand       Date:  2003-03

Review 6.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles.

Authors:  Mariet W Elting; Janet Kwee; Ted J M Korsen; Lyset T M Rekers-Mombarg; Joop Schoemaker
Journal:  Fertil Steril       Date:  2003-05       Impact factor: 7.329

8.  Ovarian age-related responsiveness to human chorionic gonadotropin.

Authors:  Terhi Piltonen; Riitta Koivunen; Aimo Ruokonen; Juha S Tapanainen
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

Authors:  Pascal Pigny; Emilie Merlen; Yann Robert; Christine Cortet-Rudelli; Christine Decanter; Sophie Jonard; Didier Dewailly
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

Review 10.  Polycystic ovary syndrome and cardiovascular disease: a premature association?

Authors:  Richard S Legro
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

View more
  32 in total

Review 1.  Industrial endocrine disruptors and polycystic ovary syndrome.

Authors:  E Palioura; E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

Review 2.  Women and Autism Spectrum Disorder: Diagnosis and Implications for Treatment of Adolescents and Adults.

Authors:  Renée M Green; Alyssa M Travers; Yamini Howe; Christopher J McDougle
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

3.  Developmental programming: prenatal testosterone-induced epigenetic modulation and its effect on gene expression in sheep ovary†.

Authors:  Niharika Sinha; Sambit Roy; Binbin Huang; Jianrong Wang; Vasantha Padmanabhan; Aritro Sen
Journal:  Biol Reprod       Date:  2020-04-24       Impact factor: 4.285

Review 4.  Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review.

Authors:  Bhaskar Venkata Kameswara Subrahmanya Lakkakula; Maheswari Thangavelu; Usha Rani Godla
Journal:  J Assist Reprod Genet       Date:  2013-06-22       Impact factor: 3.412

5.  The impact of prenatal exposure to a single dose of testosterone on insulin resistance, glucose tolerance and lipid profile of female rat's offspring in adulthood.

Authors:  M Noroozzadeh; F Ramezani Tehrani; K Sedaghat; A Godini; F Azizi
Journal:  J Endocrinol Invest       Date:  2014-12-21       Impact factor: 4.256

6.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 7.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

8.  Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.

Authors:  Clare A Flannery; Beth Rackow; Xiangyu Cong; Elvira Duran; Daryl J Selen; Tania S Burgert
Journal:  Pediatr Diabetes       Date:  2012-08-28       Impact factor: 4.866

Review 9.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

Review 10.  Longterm management of Polycystic Ovarian Syndrome (PCOS).

Authors:  Gordon W Bates; Richard S Legro
Journal:  Mol Cell Endocrinol       Date:  2012-12-20       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.